Fresenius Medical Care AG/ DE0005785802 /
20/12/2024 16:51:15 | Chg. -1.65 | Volume | Bid02/10/2024 | Demandez à12/09/2024 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
43.75EUR | -3.62% | 517 Chiffrre d'affaires: 22,593.99 |
-Bid taille: - | -Ask la taille: - | 12.78 Mrd.EUR | 2.73% | 25.62 |
GlobeNewswire
10/06
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
07/05
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/02
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
24/08/2023
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
29/03/2022
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
14/03/2022
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
01/03/2022
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page